Although IHC staining showed that the number of CD44+ staining cells was not significantly different between the groups, the intensity of CD44+ staining were markedly weaker in tumor tissues from YM155-treated mice compared to those in tumor tissues from vehicle-treated mice (Figure 6B). Here, CD44 is linked to neoplasm.